Reports of illness resembling meningococcal disease date back to the 16th century. The
description reported by Vieusseux in 1805 is generally thought to be the first definitive …

This report updates the 2004 recommendations by the Advisory Committee on Immunization
Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC …

Subcutaneous vaccine (SC) administration is an outmoded practice which complicates
vaccine administration recommendations. Local adverse events following immunization …

During the 2003-04 influenza season, influenza A (H1), A (H3N2), and B viruses co-
circulated worldwide, and influenza A (H3N2) viruses predominated. Several Asian …

Neisseria meningitidis is the leading cause of bacterial meningitis in the United States and
worldwide. A serogroup A/C/W-135/Y polysaccharide meningococcal vaccine has been …

Meningoccocal disease has repeatedly caused outbreaks worldwide. There has been
sudden surge of cases of meningococcemia and meningococcal meningitis in early 2005 in …

The purpose of the study was to assess the association between the amount of
immunoglobulin G (IgG) and the duration of adverse effects of COVID-19 vaccinations in the …

Vaccination is a proven public health initiative, however it is imperative in the context of
increasing concerns about vaccine induced adverse reactions and a decreasing incidence …

These recommendations update information regarding the polysaccharide vaccine licensed
in the United States for use against disease caused by Neisseria meningitidis serogroups A …

Objective: To compare rates of local reactions associated with two needle sizes used to
administer routine immunisations to infants. Design: Randomised controlled trial. Setting …